Fetomaternal alloimmune thrombocytopenia: The questions that still remain

Janyne Althaus, Karin J. Blakemore

Research output: Contribution to journalReview article


Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.

Original languageEnglish (US)
Pages (from-to)633-637
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue number9
StatePublished - Aug 21 2007



  • Fetal-maternal thrombocytopenia
  • Intracranial hemorrhage
  • Neonatal alloimmune thrombocytopenia
  • Platelet alloantigens

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this